MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035)
Clinical trial NCT03217136 · COMPLETED
Trial details
- NCT number
- NCT03217136
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-03
- Primary completion
- 2020-03-16
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.